To study whether pharmacological approaches may preserve cardiac GCH1 proteins and diminish the severity of DCM, we used MG 132 to treat diabetic C57BL/6 mice for 8 weeks after 4 weeks of diabetes or nondiabetic C57BL/6 mice. Here, GCH1 is linked to familial dilated cardiomyopathy.